Core Cap Advisors, LLC Pep Gen Inc. Transaction History
Core Cap Advisors, LLC
- $2.39 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding PEPG
# of Institutions
53Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$13 Million0.26% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.76MShares$3.37 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.51MShares$1.84 Million0.0% of portfolio
-
Viking Global Investors LP1.48MShares$1.81 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.35MShares$1.65 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $28.8M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...